Chemical Composition, Antibacterial Properties, and Anti-Enzymatic Effects of Eucalyptus Essential Oils Sourced from Tunisia.

This study was conducted to examine the chemical composition of the essential oils (EOs) from six Tunisian Eucalyptus species and to evaluate their anti-enzymatic and antibiofilm activities. The EOs were obtained through hydro-distillation of dried leaves and subsequently analyzed using GC/MS. The main class of compounds was constituted by oxygenated monoterpenes, particularly prominent in E. brevifolia (75.7%), E. lehmannii (72.8%), and E. woollsiana (67%). Anti-enzymatic activities against cholinesterases, α-amylase, and α-glucosidase were evaluated using spectrophotometric methods. Notably, the E. brevifolia , E. extensa , E. leptophylla , E. patellaris , and E. woollsiana EOs displayed potent acetylcholinesterase (AChE) inhibition (IC 50 : 0.25-0.60 mg/mL), with E. lehmannii exhibiting lower activity (IC 50 : 1.2 mg/mL). E. leptophylla and E. brevifolia showed remarkable α-amylase inhibition (IC 50 : 0.88 mg/mL), while E. brevifolia and E. leptophylla significantly hindered α-glucosidase (IC 50 < 30 mg/mL), distinguishing them from other EOs with limited effects. Additionally, the EOs were assessed for their anti-biofilm properties of Gram-positive ( Staphylococcus aureus and Listeria monocytogenes ) and Gram-negative ( Acinetobacter baumannii , Pseudomonas aeruginosa and Escherichia coli ) bacterial strains. The E. extensa EO demonstrated the main antibiofilm effect against E. coli and L. monocytogenes with an inhibition > 80% at 10 mg/mL. These findings could represent a basis for possible further use of Eucalyptus EOs in the treatment of human microbial infections and/or as a coadjutant in preventing and treating Alzheimer's disease and/or diabetes mellitus.